Cilostazol Stroke Prevention Study for Antiplatelet Combination
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Cilostazol Stroke Prevention Study for Antiplatelet Combination is a clinical trial[1].
Key Facts
- Cilostazol Stroke Prevention Study for Antiplatelet Combination is in the country of Japan[2].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's instance of is recorded as clinical trial[3].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's start time is recorded as +2013-12-13T00:00:00Z[4].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's end time is recorded as +2018-12-07T00:00:00Z[5].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's main subject is recorded as cerebral infarction[6].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's number of participants is recorded as {'unit': '1', 'amount': '+1884'}[7].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's title is recorded as Cilostazol Stroke Prevention Study for Antiplatelet Combination[8].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's short name is recorded as CSPS・com[9].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}[10].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's ClinicalTrials.gov ID is recorded as NCT01995370[11].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+85'}[12].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's research intervention is recorded as aspirin[13].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's research intervention is recorded as ticlopidine[14].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's research intervention is recorded as cilostazol[15].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's research intervention is recorded as clopidogrel / acetylsalicylic acid[16].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's clinical trial phase is recorded as phase III clinical trial[17].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's research subject recruitment status is recorded as completed[18].
- Cilostazol Stroke Prevention Study for Antiplatelet Combination's study type is recorded as interventional study[19].